Global Recombinant Vaccine Market Professional Survey Report 2018

February 2018 | 103 pages | ID: G76C2DEB347EN
QYResearch

Abstracts

This report studies Recombinant Vaccine in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Merck & Co., Inc.
• Green Cross Corporation
• Pfizer, Inc.
• Sanofi S A.
• Protein Science Corporation
• GlaxoSmithKline Plc
• Novartis AG
• Bharat Biotech

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Subunit Recombinant Vaccines
• Attenuated Recombinant Vaccines
• Vector Recombinant Vaccines

By Application, the market can be split into

• Human
• Animal

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Recombinant Vaccine Market Professional Survey Report 2018

1 INDUSTRY OVERVIEW OF RECOMBINANT VACCINE

1.1 Definition and Specifications of Recombinant Vaccine
  1.1.1 Definition of Recombinant Vaccine
  1.1.2 Specifications of Recombinant Vaccine
1.2 Classification of Recombinant Vaccine
  1.2.1 Subunit Recombinant Vaccines
  1.2.2 Attenuated Recombinant Vaccines
  1.2.3 Vector Recombinant Vaccines
1.3 Applications of Recombinant Vaccine
  1.3.1 Human
  1.3.2 Animal
  1.3.3 Application
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF RECOMBINANT VACCINE

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Recombinant Vaccine
2.3 Manufacturing Process Analysis of Recombinant Vaccine
2.4 Industry Chain Structure of Recombinant Vaccine

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF RECOMBINANT VACCINE

3.1 Capacity and Commercial Production Date of Global Recombinant Vaccine Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Recombinant Vaccine Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Recombinant Vaccine Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Recombinant Vaccine Major Manufacturers in 2017

4 GLOBAL RECOMBINANT VACCINE OVERALL MARKET OVERVIEW

4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2013-2018E Global Recombinant Vaccine Capacity and Growth Rate Analysis
  4.2.2 2017 Recombinant Vaccine Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2013-2018E Global Recombinant Vaccine Sales and Growth Rate Analysis
  4.3.2 2017 Recombinant Vaccine Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2013-2018E Global Recombinant Vaccine Sales Price
  4.4.2 2017 Recombinant Vaccine Sales Price Analysis (Company Segment)

5 RECOMBINANT VACCINE REGIONAL MARKET ANALYSIS

5.1 North America Recombinant Vaccine Market Analysis
  5.1.1 North America Recombinant Vaccine Market Overview
  5.1.2 North America 2013-2018E Recombinant Vaccine Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2013-2018E Recombinant Vaccine Sales Price Analysis
  5.1.4 North America 2017 Recombinant Vaccine Market Share Analysis
5.2 China Recombinant Vaccine Market Analysis
  5.2.1 China Recombinant Vaccine Market Overview
  5.2.2 China 2013-2018E Recombinant Vaccine Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2013-2018E Recombinant Vaccine Sales Price Analysis
  5.2.4 China 2017 Recombinant Vaccine Market Share Analysis
5.3 Europe Recombinant Vaccine Market Analysis
  5.3.1 Europe Recombinant Vaccine Market Overview
  5.3.2 Europe 2013-2018E Recombinant Vaccine Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2013-2018E Recombinant Vaccine Sales Price Analysis
  5.3.4 Europe 2017 Recombinant Vaccine Market Share Analysis
5.4 Southeast Asia Recombinant Vaccine Market Analysis
  5.4.1 Southeast Asia Recombinant Vaccine Market Overview
  5.4.2 Southeast Asia 2013-2018E Recombinant Vaccine Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2013-2018E Recombinant Vaccine Sales Price Analysis
  5.4.4 Southeast Asia 2017 Recombinant Vaccine Market Share Analysis
5.5 Japan Recombinant Vaccine Market Analysis
  5.5.1 Japan Recombinant Vaccine Market Overview
  5.5.2 Japan 2013-2018E Recombinant Vaccine Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2013-2018E Recombinant Vaccine Sales Price Analysis
  5.5.4 Japan 2017 Recombinant Vaccine Market Share Analysis
5.6 India Recombinant Vaccine Market Analysis
  5.6.1 India Recombinant Vaccine Market Overview
  5.6.2 India 2013-2018E Recombinant Vaccine Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2013-2018E Recombinant Vaccine Sales Price Analysis
  5.6.4 India 2017 Recombinant Vaccine Market Share Analysis

6 GLOBAL 2013-2018E RECOMBINANT VACCINE SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2013-2018E Recombinant Vaccine Sales by Type
6.2 Different Types of Recombinant Vaccine Product Interview Price Analysis
6.3 Different Types of Recombinant Vaccine Product Driving Factors Analysis
  6.3.1 Subunit Recombinant Vaccines of Recombinant Vaccine Growth Driving Factor Analysis
  6.3.2 Attenuated Recombinant Vaccines of Recombinant Vaccine Growth Driving Factor Analysis
  6.3.3 Vector Recombinant Vaccines of Recombinant Vaccine Growth Driving Factor Analysis

7 GLOBAL 2013-2018E RECOMBINANT VACCINE SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2013-2018E Recombinant Vaccine Consumption by Application
7.2 Different Application of Recombinant Vaccine Product Interview Price Analysis
7.3 Different Application of Recombinant Vaccine Product Driving Factors Analysis
  7.3.1 Human of Recombinant Vaccine Growth Driving Factor Analysis
  7.3.2 Animal of Recombinant Vaccine Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF RECOMBINANT VACCINE

8.1 Merck & Co., Inc.
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Merck & Co., Inc. 2017 Recombinant Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Merck & Co., Inc. 2017 Recombinant Vaccine Business Region Distribution Analysis
8.2 Green Cross Corporation
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Green Cross Corporation 2017 Recombinant Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Green Cross Corporation 2017 Recombinant Vaccine Business Region Distribution Analysis
8.3 Pfizer, Inc.
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Pfizer, Inc. 2017 Recombinant Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Pfizer, Inc. 2017 Recombinant Vaccine Business Region Distribution Analysis
8.4 Sanofi S A.
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Sanofi S A. 2017 Recombinant Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Sanofi S A. 2017 Recombinant Vaccine Business Region Distribution Analysis
8.5 Protein Science Corporation
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Protein Science Corporation 2017 Recombinant Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Protein Science Corporation 2017 Recombinant Vaccine Business Region Distribution Analysis
8.6 GlaxoSmithKline Plc
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 GlaxoSmithKline Plc 2017 Recombinant Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 GlaxoSmithKline Plc 2017 Recombinant Vaccine Business Region Distribution Analysis
8.7 Novartis AG
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Novartis AG 2017 Recombinant Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Novartis AG 2017 Recombinant Vaccine Business Region Distribution Analysis
8.8 Bharat Biotech
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Bharat Biotech 2017 Recombinant Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Bharat Biotech 2017 Recombinant Vaccine Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF RECOMBINANT VACCINE MARKET

9.1 Global Recombinant Vaccine Market Trend Analysis
  9.1.1 Global 2018-2025 Recombinant Vaccine Market Size (Volume and Value) Forecast
  9.1.2 Global 2018-2025 Recombinant Vaccine Sales Price Forecast
9.2 Recombinant Vaccine Regional Market Trend
  9.2.1 North America 2018-2025 Recombinant Vaccine Consumption Forecast
  9.2.2 China 2018-2025 Recombinant Vaccine Consumption Forecast
  9.2.3 Europe 2018-2025 Recombinant Vaccine Consumption Forecast
  9.2.4 Southeast Asia 2018-2025 Recombinant Vaccine Consumption Forecast
  9.2.5 Japan 2018-2025 Recombinant Vaccine Consumption Forecast
  9.2.6 India 2018-2025 Recombinant Vaccine Consumption Forecast
9.3 Recombinant Vaccine Market Trend (Product Type)
9.4 Recombinant Vaccine Market Trend (Application)

10 RECOMBINANT VACCINE MARKETING TYPE ANALYSIS

10.1 Recombinant Vaccine Regional Marketing Type Analysis
10.2 Recombinant Vaccine International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Recombinant Vaccine by Region
10.4 Recombinant Vaccine Supply Chain Analysis

11 CONSUMERS ANALYSIS OF RECOMBINANT VACCINE

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL RECOMBINANT VACCINE MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Recombinant Vaccine
Table Product Specifications of Recombinant Vaccine
Table Classification of Recombinant Vaccine
Figure Global Production Market Share of Recombinant Vaccine by Type in 2017
Figure Subunit Recombinant Vaccines Picture
Table Major Manufacturers of Subunit Recombinant Vaccines
Figure Attenuated Recombinant Vaccines Picture
Table Major Manufacturers of Attenuated Recombinant Vaccines
Figure Vector Recombinant Vaccines Picture
Table Major Manufacturers of Vector Recombinant Vaccines
Table Applications of Recombinant Vaccine
Figure Global Consumption Volume Market Share of Recombinant Vaccine by Application in 2017
Figure Human Examples
Table Major Consumers in Human
Figure Animal Examples
Table Major Consumers in Animal
Figure Market Share of Recombinant Vaccine by Regions
Figure North America Recombinant Vaccine Market Size (Million USD) (2013-2025)
Figure China Recombinant Vaccine Market Size (Million USD) (2013-2025)
Figure Europe Recombinant Vaccine Market Size (Million USD) (2013-2025)
Figure Southeast Asia Recombinant Vaccine Market Size (Million USD) (2013-2025)
Figure Japan Recombinant Vaccine Market Size (Million USD) (2013-2025)
Figure India Recombinant Vaccine Market Size (Million USD) (2013-2025)
Table Recombinant Vaccine Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Recombinant Vaccine in 2017
Figure Manufacturing Process Analysis of Recombinant Vaccine
Figure Industry Chain Structure of Recombinant Vaccine
Table Capacity and Commercial Production Date of Global Recombinant Vaccine Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Recombinant Vaccine Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Recombinant Vaccine Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Recombinant Vaccine Major Manufacturers in 2017
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Recombinant Vaccine 2013-2018E
Figure Global 2013-2018E Recombinant Vaccine Market Size (Volume) and Growth Rate
Figure Global 2013-2018E Recombinant Vaccine Market Size (Value) and Growth Rate
Table 2013-2018E Global Recombinant Vaccine Capacity and Growth Rate
Table 2017 Global Recombinant Vaccine Capacity (K Doses) List (Company Segment)
Table 2013-2018E Global Recombinant Vaccine Sales (K Doses) and Growth Rate
Table 2017 Global Recombinant Vaccine Sales (K Doses) List (Company Segment)
Table 2013-2018E Global Recombinant Vaccine Sales Price (USD/Dose)
Table 2017 Global Recombinant Vaccine Sales Price (USD/Dose) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Doses) of Recombinant Vaccine 2013-2018E
Figure North America 2013-2018E Recombinant Vaccine Sales Price (USD/Dose)
Figure North America 2017 Recombinant Vaccine Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Doses) of Recombinant Vaccine 2013-2018E
Figure China 2013-2018E Recombinant Vaccine Sales Price (USD/Dose)
Figure China 2017 Recombinant Vaccine Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Doses) of Recombinant Vaccine 2013-2018E
Figure Europe 2013-2018E Recombinant Vaccine Sales Price (USD/Dose)
Figure Europe 2017 Recombinant Vaccine Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Doses) of Recombinant Vaccine 2013-2018E
Figure Southeast Asia 2013-2018E Recombinant Vaccine Sales Price (USD/Dose)
Figure Southeast Asia 2017 Recombinant Vaccine Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Doses) of Recombinant Vaccine 2013-2018E
Figure Japan 2013-2018E Recombinant Vaccine Sales Price (USD/Dose)
Figure Japan 2017 Recombinant Vaccine Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Doses) of Recombinant Vaccine 2013-2018E
Figure India 2013-2018E Recombinant Vaccine Sales Price (USD/Dose)
Figure India 2017 Recombinant Vaccine Sales Market Share
Table Global 2013-2018E Recombinant Vaccine Sales (K Doses) by Type
Table Different Types Recombinant Vaccine Product Interview Price
Table Global 2013-2018E Recombinant Vaccine Sales (K Doses) by Application
Table Different Application Recombinant Vaccine Product Interview Price
Table Merck & Co., Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2017 Merck & Co., Inc. Recombinant Vaccine Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2017 Merck & Co., Inc. Recombinant Vaccine Business Region Distribution
Table Green Cross Corporation Information List
Table Product A Overview
Table Product B Overview
Table 2017 Green Cross Corporation Recombinant Vaccine Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2017 Green Cross Corporation Recombinant Vaccine Business Region Distribution
Table Pfizer, Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2015 Pfizer, Inc. Recombinant Vaccine Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2017 Pfizer, Inc. Recombinant Vaccine Business Region Distribution
Table Sanofi S A. Information List
Table Product A Overview
Table Product B Overview
Table 2017 Sanofi S A. Recombinant Vaccine Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2017 Sanofi S A. Recombinant Vaccine Business Region Distribution
Table Protein Science Corporation Information List
Table Product A Overview
Table Product B Overview
Table 2017 Protein Science Corporation Recombinant Vaccine Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2017 Protein Science Corporation Recombinant Vaccine Business Region Distribution
Table GlaxoSmithKline Plc Information List
Table Product A Overview
Table Product B Overview
Table 2017 GlaxoSmithKline Plc Recombinant Vaccine Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2017 GlaxoSmithKline Plc Recombinant Vaccine Business Region Distribution
Table Novartis AG Information List
Table Product A Overview
Table Product B Overview
Table 2017 Novartis AG Recombinant Vaccine Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2017 Novartis AG Recombinant Vaccine Business Region Distribution
Table Bharat Biotech Information List
Table Product A Overview
Table Product B Overview
Table 2017 Bharat Biotech Recombinant Vaccine Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2017 Bharat Biotech Recombinant Vaccine Business Region Distribution
Figure Global 2018-2025 Recombinant Vaccine Market Size (K Doses) and Growth Rate Forecast
Figure Global 2018-2025 Recombinant Vaccine Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Recombinant Vaccine Sales Price (USD/Dose) Forecast
Figure North America 2018-2025 Recombinant Vaccine Consumption Volume (K Doses) and Growth Rate Forecast
Figure China 2018-2025 Recombinant Vaccine Consumption Volume (K Doses) and Growth Rate Forecast
Figure Europe 2018-2025 Recombinant Vaccine Consumption Volume (K Doses) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Recombinant Vaccine Consumption Volume (K Doses) and Growth Rate Forecast
Figure Japan 2018-2025 Recombinant Vaccine Consumption Volume (K Doses) and Growth Rate Forecast
Figure India 2018-2025 Recombinant Vaccine Consumption Volume (K Doses) and Growth Rate Forecast
Table Global Sales Volume (K Doses) of Recombinant Vaccine by Type 2018-2025
Table Global Consumption Volume (K Doses) of Recombinant Vaccine by Application 2018-2025
Table Traders or Distributors with Contact Information of Recombinant Vaccine by Region